Clinical Trial Update: Methylphenidate in KBG Syndrome: N-of-1 Series [Phase 4]

View source ↗

Summary

Phase 4 N-of-1 clinical trial update evaluating methylphenidate for symptoms in individuals with KBG syndrome and ADHD combined type; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention-deficit Hyperactivity Disorder Combined Type
• Kbg Syndrome

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Kbg Syndrome, ADHD - Combined Type | Phase 4 | Status: RECRUITING